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LETTERS
Human Rabies in
China 
To the Editor: Rabies has occurred
in China for >2,000 years and was first
described in ≈556 BC (1). Since 1950,
human rabies has been a class II noti-
fiable disease in China, and the annual
number and distribution of human
rabies cases have been archived. We
examined the archived data from 1950
to 2004 and analyzed epidemiologic
characteristics.
During the 55-year period,
108,412 human rabies cases were
recorded in China. The Figure shows
the number of annual cases from 1950
to 2004; 3 major epidemics of human
rabies in China are apparent. In the
early 1950s, only a few cases
occurred; the first peak occurred from
1956 to 1957 with ≈2,000 cases each
year. Then the number of cases
declined during subsequent years and
was relatively constant throughout the
1960s. By 1969, the number of cases
increased again to ≈2,000. This
ascending phase continued through-
out the 1970s and 1980s. The second
epidemic peaked in the early 1980s.
In 1981, 7,037 cases were recorded,
the largest number of cases in a single
year during the 55-year period.
During the 1980s, 55,367 cases were
reported (>5,000 cases annually), rep-
resenting >50% of the 108,412 cases
seen during the entire period. In the
early 1990s, the number of
human cases decreased
dramatically from 3,520 in
1990 to 159 in 1996.
However, this downward
trend reversed its course in
1998, and annual cases
have increased gradually
since then. In 2004, a total
of 2,651 cases were report-
ed, an increase of >16 fold
when compared with the
numbers in 1996. This
third rabies epidemic
apparently has not yet
peaked. 
The compiled data also showed
substantially more rabies cases in the
summer and autumn than in the spring
and winter. Similar seasonality was
reported in animals (2), indicating the
pattern of transmission from animals
to humans. Rabies patients range in
age from infancy to >65 years of age.
The ratio of male to female victims is
68 to 32. Although human rabies has
been reported in almost all provinces,
15 provinces have had >1,000 cumu-
lative cases each. These provinces are
Hunan, Guangdong, Sichuan,
Guangxi, Guizhou, Hubei, Jiangxi,
Shandong, Henan, Anhui, Jiangsu,
Hebei, Fujian, Yunnan, and Liaoning.
These 15 provinces account for >93%
of the total cases. Four provinces
(Hunan, Guangdong, Sichuan, and
Guangxi) have had >7,000 cumulative
cases each.
Most of the human patients were
infected with rabies by dog bites. The
number of dogs has increased gradu-
ally in China since the late 1970s.
Now ≈70% of households in Guangxi,
Guizhou, and Jiangsu, and Hunan,
where the most cases were recorded in
recent years, have >1 dog (data not
shown). However, the rate of dog vac-
cination remains ≈3%.
The rabies epidemics in China
since 1950 may be partially explained
by dog population dynamics. The first
major epidemic subsided at the end of
the 1950s and the beginning of the
1960s, coinciding with pet reduction
policy. The second major epidemic
peaked in the late 1970s and early
1980s, when economic reforms were
initiated in China and the dog popula-
tion increased dramatically. Popu-
lation immunity may also play a role
in these cyclic epidemics. However,
neither the dramatic decline of rabies
cases in the early part of 1990s nor
the initiation of the third epidemic
around the turn of the millennium
could be explained simply by dog
population dynamics. Other factors
may include untimely and inappropri-
ate postexposure treatment (3,4) and
the existence of healthy carrier dogs
(5–7). Wounds of 118 of 178 patients
were not treated; 60 of the patients
washed the wounds with soap and
water. A total of 129 (72%) patients
did not receive vaccine. Of the
remaining 49 (28%) patients, 35
received vaccination in a timely man-
ner. Two of the 178 patients received
antirabies serum intramuscularly.
Among the 49 patients who received
postexposure vaccination, 30 did not
complete the immunization require-
ments. Healthy carriers have been
detected, and rabies virus antigen was
found in 25 (10%) of 248 brain spec-
imens from healthy dogs collected
from Guangxi, Guizhou, and Jiangsu
(data not shown) in 1 study. Further
investigation is needed to confirm
these findings.
In summary, rabies remains
a public health problem in
China. Strategies to control and
prevent human rabies include
public education and aware-
ness about rabies, pet vaccina-
tion programs, elimination of
stray animals, and enhanced
postexposure management. In
addition, the large number of
rabies cases should encourage
rabies prophylaxis for foreign
travelers before they visit
China, particularly those who
might travel to rural areas.
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 12, December 2005 1983
Figure. Annual rabies cases reported in China from 1950 to 2004LETTERS
1984 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 12, December 2005
Yong-Zhen Zhang,* Cheng-Long
Xiong,* Dong-Lou Xiao,* 
Ren-Jie Jiang,† Zhao-Xiao Wang,‡
Ling-Zhu Zhang,§ and Zhen F. Fu¶
*Chinese Center for Disease Control and
Prevention, Beijing, China; †Yancheng
Municipal Center for Disease Control and
Prevention, Yanchen, China; ‡Guizhou
Center for Disease Control and Prevention,
Guiyang, China; §Guangxi Center for
Disease Control and Prevention, Nanning,
China; and ¶University of Georgia, Athens,
Georgia, USA
References
1. Wang XJ, Huang JT. Epidemiology. In: Yu
YX, editor. Rabies and rabies vaccine.
Beijing: Chinese Medicine Technology
Press; 2001. p. 127–44.
2.  Gylys L, Chomel BB, Gardner IA.
Epidemiological surveillance of rabies in
Lithuania from 1986 to 1996. Rev Sci Tech.
1998;17:691–8.
3.  Centers for Disease Control and
Prevention. Human rabies prevention—
United States, 1999; recommendations of
the Advisory Committee on Immunization
Practice (ACIP). MMWR Recomm Rep.
1999;48(RR-1):1–21.
4. Chhabra M, Ichhpujani RL, Tewari KN, Lal
S. Human rabies in Delhi. Indian J Pediatr.
2004;71:217–20.
5. Hu JY, Xu TQ, Wu ZM, Si Y, Zhao LL,
Shen RH, et al. Astudy on the epidemiolog-
ical characteristics and the preventive
measures of rabies in Shanghai [article in
Chinese]. Chin J Epidemiol. 2001;22:
11–13.
6. Du F, Huang MT, Liang FP, Luo HM, Wen
JH, Chen DR, et al. Investigation on rabies
virus in dogs in Guangdong [article in
Chinese]. Chin J Zoonoses. 1992;8:39–41.
7.  Fekadu M, Shaddock JH, Chandler FW,
Baer GM. Rabies virus in the tonsils of a
carrier dog. Arch Virol. 1983;78:37–47.
Address for correspondence: Yong-Zhen
Zhang, Institute for Infectious Disease Control
and Prevention, Chinese CDC, Liuzi 5,
Changping 102206, Beijing, 102206, China;
fax: 86-10-61739457; email: yongzhenzhang@
sohu.com
Resistant
Salmonella
Virchow in Quail
Products
To the Editor: Salmonella  spp.
resistant to multiple antimicrobial
agents have emerged worldwide in
recent years, but clinical relevance
varies with the agent to which resist-
ance evolves. Fluoroquinolones are
often the drug of choice to treat gas-
trointestinal infections in humans, and
resistance to this class of antimicro-
bial agents is associated with
increased illness and death (1).
Resistance to fluoroquinolones has
emerged worldwide during the last
decade.  Salmonella isolates resistant
to oxyiminocephalosporins because
they produce extended-spectrum β-
lactamases (ESBLs) have emerged
worldwide since 1992. This emer-
gence has caused concern since
cephalosporins are drugs of choice to
treat salmonellosis in children, to
whom fluoroquinolones must not be
administered because of toxicity
issues. In Denmark, the first ESBL-
producing isolate of animal origin
from a Salmonella enterica serovar
Heidelberg isolated from a boar
imported from Canada in 2003 was
reported (2), but such isolates have
not previously been reported in food
products.
On October 15, 2003, the Danish
Institute for Veterinary Research, the
national reference laboratory,
received 3 Salmonella isolates found
in quails imported from France.
Salmonella isolates found at any
importer’s laboratory in Denmark are
submitted to the reference laboratory
for further analyses. The quails were
in the importer’s storage room at the
time of sampling; sampling was per-
formed routinely by the importer’s
own laboratory. At the reference labo-
ratory, the isolates were serotyped as
S. enterica serovar Virchow and
found resistant to ampicillin, ceftio-
fur, cephalothin, nalidixic acid, and
tetracycline and with reduced suscep-
tibility to ciprofloxacin (MICs >0.125
µg/mL) (3). Polymerase chain reac-
tion detection and sequencing (4)
showed that the β-lactam resistance
was mediated by blaCTX-M-9. Pulsed-
field gel electrophoresis was per-
formed by using XbaI and BlnI as
restriction enzymes according to the
PulseNet protocol (5), and all 3 iso-
lates had the same profile.
On October 23, the importer was
informed of the laboratory’s findings
and the increased risk associated with
salmonella isolates simultaneously
resistant to quinolones and
cephalosporins. Based on this infor-
mation, the importer withdrew the
product from the supermarkets on
October 24. Recently, S.  enterica
Virchow with blaCTX-M-9 has also been
reported in poultry, poultry products,
and humans in France (6), as well as
humans in Spain (7) and the United
Kingdom (8). The isolates from
France were also resistant to nalidixic
acid; the isolates we have obtained
from fresh quails imported from
France are possibly related to these
isolates.
The global food-products trade is
expected to increase in the future.
Thus, attempts to improve food safety
must emphasize detection of antimi-
crobial drug–resistant bacteria in
imported food products. Furthermore,
international agreements that limit
contamination with drug-resistant
bacteria and resistance genes at the
primary production site are necessary
to ensure consumer safety (9).
International agreements must be
based on antimicrobial-resistance data
and early reports of emerging prob-
lems. Recently, the World Health
Organization (WHO) launched the
Global Salm Surv program (10) to
isolate and identify antimicrobial
resistance to Salmonella globally. 
Many national and international
rules, as well as marketing and con-
sumer factors, regulate the interna-